Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,168 | 288 | 62.4% |
| Education | $3,087 | 5 | 31.2% |
| Travel and Lodging | $630.45 | 4 | 6.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Intuitive Surgical, Inc. | $3,000 | 1 | $0 (2023) |
| COLOPLAST CORP | $1,427 | 31 | $0 (2024) |
| Astellas Pharma US Inc | $1,218 | 51 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $709.48 | 31 | $0 (2024) |
| ABBVIE INC. | $658.53 | 38 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $325.83 | 13 | $0 (2024) |
| Boston Scientific Corporation | $278.91 | 14 | $0 (2024) |
| Axonics, Inc. | $202.39 | 8 | $0 (2023) |
| Janssen Biotech, Inc. | $187.54 | 18 | $0 (2022) |
| PFIZER INC. | $149.85 | 11 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $667.74 | 29 | Sumitomo Pharma America, Inc. ($126.49) |
| 2023 | $4,169 | 48 | Intuitive Surgical, Inc. ($3,000) |
| 2022 | $1,009 | 57 | Endo Pharmaceuticals Inc. ($166.52) |
| 2021 | $789.86 | 37 | Astellas Pharma US Inc ($255.92) |
| 2020 | $917.83 | 19 | Coloplast Corp ($708.14) |
| 2019 | $944.76 | 37 | Coloplast Corp ($391.22) |
| 2018 | $518.34 | 31 | Astellas Pharma US Inc ($101.82) |
| 2017 | $868.93 | 39 | Astellas Pharma US Inc ($316.10) |
All Payment Transactions
297 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/05/2024 | Endo USA, Inc. | AVEED (Biological), XIAFLEX | Food and Beverage | In-kind items and services | $24.24 | General |
| Category: UROLOGY | ||||||
| 11/25/2024 | Tolmar, Inc. | ELIGARD (Drug) | Food and Beverage | Cash or cash equivalent | $22.02 | General |
| Category: ONCOLOGY | ||||||
| 09/11/2024 | Boston Scientific Corporation | SpaceOAR VUE System - 10mL (Device) | Food and Beverage | In-kind items and services | $46.36 | General |
| Category: SpaceOAR VUE_URO | ||||||
| 09/09/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $22.99 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/06/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: Oncology | ||||||
| 09/04/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 08/19/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $26.87 | General |
| Category: UROLOGY | ||||||
| 08/19/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: UROLOGY | ||||||
| 08/12/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $27.16 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/09/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $25.05 | General |
| Category: UROLOGY | ||||||
| 07/09/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: HORMONE THERAPY | ||||||
| 07/02/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: UROLOGY | ||||||
| 07/02/2024 | Teleflex LLC | SOLESTA (Device) | Food and Beverage | In-kind items and services | $21.92 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 06/05/2024 | Ambu Inc. | — | Food and Beverage | Cash or cash equivalent | $16.56 | General |
| 05/14/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $28.90 | General |
| Category: UROLOGY | ||||||
| 05/08/2024 | Endo USA, Inc. | AVEED (Biological) | Food and Beverage | In-kind items and services | $24.65 | General |
| Category: UROLOGY | ||||||
| 05/02/2024 | COLOPLAST CORP | Titan (Device) | Food and Beverage | In-kind items and services | $28.95 | General |
| Category: Men's Health | ||||||
| 05/01/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: ENDOCRINOLOGY | ||||||
| 04/09/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 03/25/2024 | Endo Pharmaceuticals Inc. | AVEED (Biological), XIAFLEX | Food and Beverage | In-kind items and services | $22.65 | General |
| Category: UROLOGY | ||||||
| 03/06/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 02/26/2024 | Endo Pharmaceuticals Inc. | AVEED (Biological), XIAFLEX | Food and Beverage | In-kind items and services | $23.69 | General |
| Category: UROLOGY | ||||||
| 02/20/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $24.09 | General |
| Category: UROLOGY | ||||||
| 02/08/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $24.14 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 1,711 | 21,256 | $695,074 | $202,715 |
| 2022 | 24 | 1,624 | 16,442 | $590,486 | $165,219 |
| 2021 | 27 | 1,963 | 21,502 | $713,258 | $209,046 |
| 2020 | 27 | 1,756 | 28,680 | $589,350 | $177,384 |
All Medicare Procedures & Services
105 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 388 | 656 | $203,990 | $58,110 | 28.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 462 | 582 | $128,348 | $34,927 | 27.2% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 111 | 134 | $77,295 | $23,723 | 30.7% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 20 | 139 | $46,939 | $18,848 | 40.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 102 | 102 | $41,728 | $11,771 | 28.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 84 | 93 | $40,269 | $9,226 | 22.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 56 | 116 | $20,956 | $7,199 | 34.4% |
| 52601 | Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | Facility | 2023 | 11 | 11 | $20,458 | $6,234 | 30.5% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 16 | 16 | $16,894 | $5,409 | 32.0% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Office | 2023 | 18 | 18 | $13,899 | $4,459 | 32.1% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 22 | 22 | $12,951 | $3,775 | 29.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 34 | 62 | $10,044 | $2,633 | 26.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 17 | 17 | $7,395 | $2,339 | 31.6% |
| 51720 | Instillation of anti-cancer drug into bladder | Office | 2023 | 11 | 32 | $6,816 | $2,186 | 32.1% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 17 | 21 | $9,207 | $2,117 | 23.0% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 150 | 172 | $4,306 | $1,311 | 30.4% |
| 52005 | Insertion of tube into ureter using an endoscope through bladder area | Facility | 2023 | 13 | 13 | $4,225 | $1,237 | 29.3% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 17 | 18 | $7,794 | $1,196 | 15.4% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 14 | 23 | $4,005 | $1,156 | 28.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 11 | 12 | $3,084 | $1,109 | 36.0% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 21 | 21 | $2,955 | $949.20 | 32.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 26 | 87 | $3,045 | $868.45 | 28.5% |
| 76857 | Limited ultrasound scan of pelvis | Office | 2023 | 24 | 24 | $2,835 | $866.18 | 30.6% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 19 | 24 | $3,888 | $406.18 | 10.4% |
| 74420 | Imaging of urinary tract following injection of a contrast agent | Facility | 2023 | 16 | 19 | $1,299 | $362.52 | 27.9% |
About Dr. Eric Diner, M.D
Dr. Eric Diner, M.D is a Urology healthcare provider based in St. Petersburg, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1659473940.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Diner, M.D has received a total of $9,885 in payments from pharmaceutical and medical device companies, with $667.74 received in 2024. These payments were reported across 297 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($6,168).
As a Medicare-enrolled provider, Diner has provided services to 7,054 Medicare beneficiaries, totaling 87,880 services with total Medicare billing of $754,365. Data is available for 4 years (2020–2023), covering 105 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location St. Petersburg, FL
- Active Since 09/05/2006
- Last Updated 03/29/2022
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1659473940
Products in Payments
- DAVINCI XI (Device) $3,000
- ALTIS (Device) $630.45
- XIAFLEX (Biological) $573.93
- XTANDI (Drug) $567.50
- GEMTESA (Drug) $398.98
- TITAN (Device) $326.57
- LUPRON DEPOT (Drug) $289.00
- Myrbetriq (Drug) $275.61
- SpeediCath (Device) $251.04
- AVEED (Biological) $231.52
- BOTOX (Biological) $194.27
- Axonics (Device) $193.79
- Xtandi (Drug) $191.42
- ERLEADA (Drug) $187.54
- AQUABEAM ROBOTIC SYSTEM (Device) $141.44
- ELIGARD (Drug) $131.07
- TOVIAZ (Drug) $109.46
- Androgel (Drug) $103.29
- ORGOVYX (Drug) $90.42
- SPEEDICATH (Device) $86.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.